Cardiometabolism and Interorgan Crosstalk: Novel Mechanisms and Therapies (B2)
February 15-19, 2027
| Beaver Run Conference Center, Breckenridge, CO, United States
Saptarsi M. Haldar, Karol E. Watson and David A Kass
Saturday, January 6, 2007
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
Saturday, January 2, 2027
| 4:00–5:00 PM |
Welcome and Keynote Address |
|
| |
Daniel J. Drucker †, Lunenfeld-Tanenbaum Research Institute
Mechanisms of Incretin Therapy and their CV and Neurological Benefits |
|
| 5:00–7:00 PM |
Nervous System Crosstalk in Cardiometabolic Disease |
|
| |
Randy J. Seeley †, University of Michigan
The Central Nervous System in Cardiometabolic Disease Pathogenesis and Therapy |
|
| |
Daniela Carnevale †, University La Sapienza in Rome
Heart-Brain-Splenic Axis and Control of Heart Failure and Hypertension |
|
| |
Filip K. Swirski †, Icahn School of Medicine at Mount Sinai
Novel Immune/Neural Mechanisms in Cardiometabolic Disease |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 8:00–11:00 AM |
Skeletal Muscle, Renal, and Vascular Crosstalk and CV Disease |
|
| |
Zoltan Arany †, University of Pennsylvania
Rerouting Metabolic Fuel Flux Utilization across Organs in Cardiometabolic Disease |
|
| |
Flora Sam †, Eli Lilly
Skeletal Muscle Myokines and HFpEF |
|
| |
Kristin I. Stanford †, Ohio State University
Exercise, Adipose & Metabolic Crosstalk |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–12:00 PM |
Panel Discussion: AI Tools in Cardiometabolic Research |
|
| 12:00–1:00 PM |
Poster Setup |
|
| 12:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions |
|
| |
Short Talks Chosen from Abstracts
|
|
| 3:00–4:30 PM |
Career Roundtable |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Immune System Crosstalk in Cardiovascular and Metabolic Disease |
|
| |
Kory J. Lavine †, Washington University School of Medicine
Single Cell Epigenomics to Reveal Cellular Crosstalk in CV Disease |
|
| |
Diane Mathis †, Harvard Medical School
Immune Modulation of Skeletal Muscle Function and Exercise Adaptation |
|
| |
Pradeep Natarajan †, Massachusetts General Hospital
Clonal Hematopoiesis in CVD |
|
| |
Han Zhu †, Stanford University
T Lymphocyte Subsets in Cardiovascular Homeostasis and Response to Cancer Immunotherapy |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Emerging Cardiometabolic Therapeutics |
|
| |
William A. Chutkow †, Novartis Institute for Biomedical Research
Targeting Lean Muscle Mass in Cardiovascular and Metabolic Disease |
|
| |
Ambarish Pandey †, UT Southwestern Medical Center
Who Responds Best to GLP-1R Agonists? -- an AI based Approach |
|
| |
Speaker to be Announced
Novel Nucleic Acid-based Therapeutic Platforms in Cardiovascular and Metabolic Disease |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–6:45 PM |
Target Discovery and Patient Segmentation in Cardiometabolic Disease: AI and Human Genetics |
|
| |
Luca Lotta †, Regeneron Pharmaceuticals Inc.
Human Genetics at the Intersection of Metabolism and CV Risk |
|
| |
Rajat Gupta †, Massachusetts General Hospital
Functional Genomics and Perturbational Screening for Cardiometabolic Target Discovery |
|
| |
Anna Helgadottir †, Decode genetics
Metabolic Drivers of CVD and Implications for Clinical Trial Enrichment |
|
| |
Rohan Khera †, Yale University
AI-based Approaches for Precision Care and CV Outcomes Research |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Adiposity, Diabetes and Clinical CV Disease |
|
| |
David A. Kass, Johns Hopkins Hospital
Obesity + HFpEF = Bad Sarcomeres |
|
| |
Karol E. Watson, University of California, Los Angeles
Novel Insights from the DPPOS Cohort |
|
| |
Saptarsi M. Haldar, Amgen Inc.
Novel Approaches to Treating Obesity and Adiposity-Related Diseases |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 PM |
Coffee Break |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:30–6:45 PM |
Novel Mechanisms of Liver, Adipose and Cardiovascular Crosstalk |
|
| |
Isha Jain †, Arc Institute and Gladstone/UCSF
Hypoxic Signaling and Interorgan Crosstalk in Physiology & Disease |
|
| |
E. Dale Abel †, David Geffen School of Medicine and UCLA Health
Insulin Signaling, Mitochondria and Metabolic Heart Disease |
|
| |
Katrin J. Svensson †, Stanford University
Novel Peptides as Obesity Therapeutic Targets |
|
| |
Gabriele G Schiattarella †, Charité University Medical Center
Cardiometabolic-Hepatic Crosstalk |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
|
| 8:00–11:00 PM |
Entertainment |
|
